Tag: Novo Nordisk A/S

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

U.S. executives, from Apple to Eli Lilly, revamp their push into the world’s second-largest economy at the China Development Forum

Danone to buy protein shake maker Huel as health nutrition craze drives demand shift

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

Eli Lilly shares slide after a bearish Wall Street analyst call — here’s our view